The relationship between transformational leadership and innovative behaviour in a healthcare context:a team learning versus a cohesion perspective

The purpose of this study was to explore whether the relationship between transformational leadership and innovative behaviour is explained via the mediating role of team learning, or whether instead team cohesion mediates this relationship. Using survey data from 158 professionals within 21 teams in the Dutch healthcare context, we tested by means of hierarchical regression analyses: (a) the relationship between transformational leadership and innovative behaviour; (b) whether team learning or cohesion mediates this relationship; and (c) the relationship between team learning and cohesion, in relation to transformational leadership. Results showed that transformational leadership is positively related to innovative behaviour and that both cohesion and team learning mediate this relationship, with team learning being the strongest mediator. Addressing a neglected area, our study provides evidence to show that managers who enhance team learning are likely to maximise employees' scope for engaging in innovative behaviours. © 2012 Inderscience Enterprises Ltd.

Drake v Ipsos Mori Ltd 2012

Case law report - online

Dziedziak v Future Electronics Ltd

Case law report - online

F and G Cleaners Ltd v Saddington 2012

Case law report - online

Heafield v The Times Newspaper Ltd 2012

Case law report - online

Nottingham City Transport Ltd v Harvey

Case law report - online

P F Franco v Fyffes Ltd

Case law report - online

Patsystems Ltd v Neilly 2012

Case law report - online

R v Lion Steel Equipment Ltd 2012

Case law report - online

Safetynet Security Ltd v Coppage 2012

Case law report - online

Trago Mills (South Devon) Ltd v Information Commissioner 2012

Case law report - online

Welton v Deluxe Retail Ltd 2012

Case law report - online

Buzoli v Food Partners Ltd 2012

Case law report - online

Threlfall v ECD Insight Ltd and others 2012

Case law report - online

Estimating the scope for savings in referrals and drug prescription costs in the general Practice units of a UK primary care trust

This paper explores the potential for cost savings in the general Practice units of a Primary Care Trust (PCT) in the UK. We have used Data Envelopment Analysis (DEA) to identify benchmark Practices, which offer the lowest aggregate referral and drugs costs controlling for the number, age, gender, and deprivation level of the patients registered with each Practice. For the remaining, non-benchmark Practices, estimates of the potential for savings on referral and drug costs were obtained. Such savings could be delivered through a combination of the following actions: (i) reducing the levels of referrals and prescriptions without affecting their mix (£15.74 m savings were identified, representing 6.4% of total expenditure); (ii) switching between inpatient and outpatient referrals and/or drug treatment to exploit differences in their unit costs (£10.61 m savings were identified, representing 4.3% of total expenditure); (iii) seeking a different profile of referral and drug unit costs (£11.81 m savings were identified, representing 4.8% of total expenditure). © 2012 Elsevier B.V. All rights reserved.